Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 751 to 800 of 2027

TitleReference numberPublishedLast updated
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failedTA715
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal)TA714
Enzalutamide for treating hormone-sensitive metastatic prostate cancerTA712
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapyTA713
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillationTA249
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA355
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillationTA256
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA275
Atrial fibrillation: diagnosis and managementNG196
Plus Sutures for preventing surgical site infectionHTG586
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA709
Ravulizumab for treating atypical haemolytic uraemic syndromeTA710
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitisTA708
Laser lithotripsy for difficult-to-treat bile duct stonesHTG584
Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valveHTG585
Patient experience in adult NHS services: improving the experience of care for people using adult NHS servicesCG138
Shared decision makingNG197
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancerTA707
Autism spectrum disorder in adults: diagnosis and managementCG142
Autism spectrum disorder in under 19s: support and managementCG170
Ozanimod for treating relapsing–remitting multiple sclerosisTA706
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplantHTG580
Transvaginal laser therapy for stress urinary incontinenceHTG581
Transvaginal laser therapy for urogenital atrophyHTG582
Electrohydraulic lithotripsy for difficult-to-treat bile duct stonesHTG583
Heavy menstrual bleeding: assessment and managementNG88
Ravulizumab for treating paroxysmal nocturnal haemoglobinuriaTA698
Ofatumumab for treating relapsing multiple sclerosisTA699
Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal)TA701
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiographyHTG429
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcersHTG355
Permanent His-bundle pacemaker implantation for treating heart failureHTG579
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasiaHTG578
Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA692
Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA694
Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myelomaTA695
Repetitive short-pulse transscleral cyclophotocoagulation for glaucomaHTG576
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adultsHTG577
Acalabrutinib for treating chronic lymphocytic leukaemiaTA689
Avelumab for untreated metastatic Merkel cell carcinomaTA691
Avelumab for treating metastatic Merkel cell carcinomaTA517
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liverHTG575
Postnatal careNG194
Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary painNG193
Anakinra for treating Still's diseaseTA685
Blinatumomab for previously treated Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal)TA686

Results per page

  1. 10
  2. 25
  3. 50
  4. All